1
|
Counter CM, Avilion AA, LeFeuvre CE, et
al: Telomere shortening associated with chromosome instability is
arrested in immortal cells which express telomerase activity. EMBO
J. 11:1921–1929. 1992.PubMed/NCBI
|
2
|
Kim NW, Piatyszek MA, Prowse KR, et al:
Specific association of human telomerase activity with immortal
cells and cancer. Science. 266:2011–2015. 1994. View Article : Google Scholar : PubMed/NCBI
|
3
|
Shay JW and Wright WE: Telomerase activity
in human cancer. Curr Opin Oncol. 8:66–71. 1996. View Article : Google Scholar
|
4
|
Colangelo D and Osella D: Telomerase
inhibition and cancer: might platinum based drugs have a future as
anti-telomerase pharmacological approach? Curr Med Chem.
12:3091–3102. 2005. View Article : Google Scholar : PubMed/NCBI
|
5
|
Schiffer CA: Treatment of high-grade
lymphoid malignancies in adults. Semin Hematol. 38(4 Suppl 10):
22–26. 2001. View Article : Google Scholar : PubMed/NCBI
|
6
|
Tomizawa A, Kanno S, Osanai Y, et al:
Induction of apoptosis by a potent caffeic acid derivative, caffeic
acid undecyl ester, is mediated by mitochondrial damage in NALM-6
human B cell leukemia cells. Oncol Rep. 29:425–429. 2013.PubMed/NCBI
|
7
|
Uwai K, Osanai Y, Imaizumi T, Kanno S,
Takeshita M and Ishikawa M: Inhibitory effect of the alkyl side
chain of caffeic acid analogues on lipopolysaccharide-induced
nitric oxide production in RAW264.7 macrophages. Bioorg Med Chem.
16:7795–7803. 2008. View Article : Google Scholar : PubMed/NCBI
|
8
|
Kanno S, Maeda N, Tomizawa A, Yomogida S,
Katoh T and Ishikawa M: Involvement of p21waf1/cip1 expression in
the cytotoxicity of the potent histone deacetylase inhibitor
spiruchostatin B towards susceptible NALM-6 human B cell leukemia
cells. Int J Oncol. 40:1391–1396. 2012.PubMed/NCBI
|
9
|
Watanabe K, Kanno S, Tomizawa A, Yomogida
S and Ishikawa M: Acacetin induces apoptosis in human T cell
leukemia Jurkat cells via activation of a caspase cascade. Oncol
Rep. 27:204–209. 2012.PubMed/NCBI
|
10
|
Kanno S, Higurashi A, Watanabe Y, Shouji
A, Asou K and Ishikawa M: Susceptibility to cytosine arabinoside
(Ara-C)-induced cytotoxicity in human leukemia cell lines. Toxicol
Lett. 152:149–158. 2004.PubMed/NCBI
|
11
|
Greider CW: Telomerase activation. One
step on the road to cancer? Trends Genet. 15:109–112. 1999.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Martens UM, Brass V, Sedlacek L, et al:
Telomere maintenance in human B lymphocytes. Br J Haematol.
119:810–818. 2002. View Article : Google Scholar : PubMed/NCBI
|
13
|
Ozturk G, Ginis Z, Akyol S, Erden G, Gurel
A and Akyol O: The anticancer mechanism of caffeic acid phenethyl
ester (CAPE): review of melanomas, lung and prostate cancers. Eur
Rev Med Pharmacol Sci. 16:2064–2068. 2012.PubMed/NCBI
|
14
|
Braun T, Carvalho G, Fabre C, Grosjean J,
Fenaux P and Kroemer G: Targeting NF-kappaB in hematologic
malignancies. Cell Death Differ. 13:748–758. 2006. View Article : Google Scholar : PubMed/NCBI
|
15
|
Yin L, Hubbard AK and Giardina C: NF-kappa
B regulates transcription of the mouse telomerase catalytic
subunit. J Biol Chem. 275:36671–36675. 2000. View Article : Google Scholar : PubMed/NCBI
|
16
|
Ghosh A, Saginc G, Leow SC, et al:
Telomerase directly regulates NF-κB-dependent transcription. Nat
Cell Biol. 14:1270–1281. 2012.
|
17
|
Lobetti-Bodoni C, Bernocco E, Genuardi E,
Boccadoro M and Ladetto M: Telomeres and telomerase in normal and
malignant B-cells. Hematol Oncol. 28:157–167. 2010. View Article : Google Scholar : PubMed/NCBI
|